Fisher & Paykel Healthcare shares take hit on renewed tariff fears

Fisher & Paykel Healthcare shares take hit on renewed tariff fears
The US Department of Commerce has launched a “Section 232” on medical products. (Image: Supplied)
Gregor Thompson
Fisher & Paykel Healthcare shares have taken a hit from renewed tariff concerns following the United States' announcement of a national security investigation into medical equipment.      A document published by the US Department of Commerce (DOC) on Thursday revealed that it has launched a “Section 232” investigation into whether imports of personal protective equipment (PPE), medical consumables, and medical equipment pose a risk to national security.Fisher & Paykel Healthcare, the NZX 50’s largest...

More Markets

NZ sharemarket falls despite positive Fonterra result
Markets Market Close

NZ sharemarket falls despite positive Fonterra result

The S&P/NZX 50 Index closed down 0.21% or 27.52 points.

Air NZ CEO Greg Foran lays bare engine woes
Markets

Air NZ CEO Greg Foran lays bare engine woes

Air NZ has two of the most problematic engines in the world at the moment, CEO says.

Fonterra’s milk supply deal with Lactalis ‘two-edged sword’
Primary Sector

Fonterra’s milk supply deal with Lactalis ‘two-edged sword’

Fonterra would need to build “long-term strategic relationship” if it sells to Lactalis.

Ebos’ earnings is ‘most diversified ever’: Forbar
Markets

Ebos’ earnings is ‘most diversified ever’: Forbar

Forsyth Barr upgraded the dual-listed stock from neutral to outperform.